Alnylam Pharmaceuticals, Inc. (ALNY)
300.58
+2.10
(+0.70%)
USD |
NASDAQ |
May 21, 16:00
302.00
+1.42
(+0.47%)
After-Hours: 17:13
Alnylam Pharmaceuticals Total Liabilities (Quarterly) : 4.054B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 24.33M |
| Ionis Pharmaceuticals, Inc. | 2.959B |
| Gilead Sciences, Inc. | 32.85B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Sarepta Therapeutics, Inc. | 1.674B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.130B |
| Shareholders Equity (Quarterly) | 1.075B |
| Debt to Equity Ratio | 2.762 |
| Current Ratio | 3.127 |
| Net Debt Paydown Yield | -0.10% |